Literature DB >> 9930355

Oral cancer in the UK: to screen or not to screen.

V C Rodrigues1, S M Moss, H Tuomainen.   

Abstract

Although oral squamous cell carcinoma accounts for only a small proportion of malignant neoplasms in the UK, oral cancer incidence and mortality rates have been rising in recent years. The natural history of oral cancer is not adequately understood at present and there is very little information about the epidemiology of precancerous lesions in the UK. There are also insufficient data to provide firm evidence that the percentage of cases arising de novo is greater in the UK and the Western world as compared to the Indian subcontinent. Screening for oral cancer by visual examination is simple, inexpensive and causes little discomfort; however, there is no evidence for the effectiveness of screening for oral cancer either in reducing mortality from the disease or in reducing the incidence of invasive disease by detection and treatment of precancerous lesions. There is currently insufficient evidence to recommend population screening for oral cancer in the UK. Measures aimed at primary prevention of the disease may be a more feasible method of disease control at present.

Entities:  

Mesh:

Year:  1998        PMID: 9930355     DOI: 10.1016/s1368-8375(98)00052-9

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  19 in total

1.  Oral cancer.

Authors:  C Scully; S Porter
Journal:  West J Med       Date:  2001-05

2.  The association of smoking, alcoholic consumption, betel quid chewing and oral cavity cancer: a cohort study.

Authors:  Tin-Tin Yen; Whe-Dar Lin; Ching-Ping Wang; Chen-Chi Wang; Shih-An Liu
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-04-04       Impact factor: 2.503

3.  Over-expression of Gadd45a enhances radiotherapy efficacy in human Tca8113 cell line.

Authors:  Xiao-ying Zhang; Xun Qu; Cheng-qin Wang; Cheng-jun Zhou; Gui-xiang Liu; Feng-cai Wei; Shan-zhen Sun
Journal:  Acta Pharmacol Sin       Date:  2011-02       Impact factor: 6.150

4.  PTEN-mediated AKT activation contributes to the reduced apoptosis among Indian oral squamous cell carcinoma patients.

Authors:  Nisreen Sherif Alyasiri; Syed Jafar Mehdi; M Shabbir Alam; Asgar Ali; Ashish K Mandal; Sunita Gupta; Ishwar Singh; M Moshahid Alam Rizvi
Journal:  J Cancer Res Clin Oncol       Date:  2011-10-28       Impact factor: 4.553

5.  Viable bacteria present within oral squamous cell carcinoma tissue.

Authors:  Samuel J Hooper; St John Crean; Michael A O Lewis; David A Spratt; William G Wade; Melanie J Wilson
Journal:  J Clin Microbiol       Date:  2006-05       Impact factor: 5.948

6.  Oxidative DNA damage is a preliminary step during rat tongue carcinogenesis induced by 4-nitroquinoline 1-oxide.

Authors:  Sandra Regina Miranda; Juliana Noguti; Juliana Gonçalves Carvalho; Celina Tijuko Fujiyama Oshima; Daniel Araki Ribeiro
Journal:  J Mol Histol       Date:  2011-03-23       Impact factor: 2.611

7.  Effect of Mangrove Tea Extract from Ceriops decandra (Griff.) Ding Hou. on Salivary Bacterial Flora of DMBA Induced Hamster Buccal Pouch Carcinoma.

Authors:  Natarajan Sithranga Boopathy; Kathiresan Kandasamy; Manivannan Subramanian; Jeon You-Jin
Journal:  Indian J Microbiol       Date:  2011-02-27       Impact factor: 2.461

8.  Oral cancer report from Northeastern Hungary.

Authors:  Judit A Nemes; Pál Redl; Róbert Boda; Csongor Kiss; Ildikó J Márton
Journal:  Pathol Oncol Res       Date:  2008-03-20       Impact factor: 3.201

9.  Overexpression of chemerin was associated with tumor angiogenesis and poor clinical outcome in squamous cell carcinoma of the oral tongue.

Authors:  Ning Wang; Qing-Jie Wang; Yuan-Yong Feng; Wei Shang; Min Cai
Journal:  Clin Oral Investig       Date:  2013-07-19       Impact factor: 3.573

10.  Frequent inactivation of RUNX3 by promoter hypermethylation and protein mislocalization in oral squamous cell carcinomas.

Authors:  Feng Gao; Canhua Huang; Mei Lin; Zhi Wang; Jun Shen; Haiyuan Zhang; Lu Jiang; Qianming Chen
Journal:  J Cancer Res Clin Oncol       Date:  2008-11-18       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.